Investing With IBD cover image

Ep. 84: Austin Lieberman: Why Investors Shouldn't Be Afraid Of Expensive Stocks

Investing With IBD

00:00

Zoom's 600% Year-to-Double Run Up

A lot of times, if it goes over $100 a share, that's a big positive for me. If it has a great company and now it's hitting over $100, these days, I'm focusing on most of my stocks are over $100. They've done that well to get over that price and they just actually might be getting rolling at that time where they can go from 100 to 200 pretty quickly. zoom is going to continue to outperform the market.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app